The role of past sun exposure in Multiple Sclerosis by van der Mei, IAF
The role of past sun exposure in Multiple Sclerosis
by
Ingrid A.F. van der Mei
'RFWRUDQGXV0DVWHU¶V
Environmental Health Sciences, Human Movement Sciences
A thesis submitted in fulfilment of the requirements for the degree of
Doctor of Philosophy
University of Tasmania (September, 2004)

iDECLARATION
This Thesis contains no material which has been accepted for any degree or diploma by the
University or any other institution, except by way of background information and duly
acknowledged in the Thesis, and to the best of my knowledge and belief no material
previously published or written by another person, except where due acknowledgement is
made in the text of the Thesis.
AUTHORITY OF ACCESS
This Thesis may be made available for loan and limited copying in accordance with the
Copyright Act 1968
SIGNATURE
Ingrid A.F. van der Mei
ii
ABSTRACT
This epidemiological thesis firstly reviews the disease Multiple Sclerosis (MS): its history,
pathology, clinical expression, and the current views on immunopathogenesis, aetiology and
treatment. A separate review on ultraviolet radiation (UVR) and MS indicates that recent work
in photoimmunology provides evidence that UVR can attenuate T helper 1 cell mediated
processes through several mechanisms, and that epidemiological features of MS, such as the
striking latitudinal gradient and seasonal variation in month of birth, MS onset and disease
activity, are at least in part consistent with the hypothesis that UVR exposure may reduce the
risk of MS. An ecological analysis was conducted as part of the PhD to demonstrate that
regional variation in MS prevalence in the continent of Australia could be closely predicted by
regional UVR levels, but analytical epidemiological studies are required to further investigate
the UVR hypothesis.
The project central to this thesis was a population based case-control study on Multiple
Sclerosis, conducted in Tasmania, Australia. It examined: (i) whether high past sun exposure
was associated with a reduced risk of MS, (ii) whether sibship structure and past infections
influenced the risk of MS and (iii) whether having had children and differences in prevalence
and strength of MS risk factors between men and women could explain the sex difference in
MS. Interviews were conducted with 136 cases with MS and 272 controls randomly drawn
from the community and matched on sex and birth year. In one of the methodology chapters,
a measure-retest and method comparison was conducted to examine aspects of reliability of
the sun exposure measures used in the case-control study. A separate study on 104 healthy
volunteers was carried out to examine the effect of seasonal variation and body hair on
melanin density estimates based on skin reflectance.
The case-control study showed that higher past sun exposure, particularly during childhood
and early adolescence, was associated with a reduced risk of MS, which is compatible with
UVR having a protective role against MS. Having younger siblings, but not older siblings, was
also associated with a reduced risk of MS, while having had glandular fever or having high
antibody titers against the Epstein-Barr virus was associated with an increased risk of MS.
Among women, a negative association was found between having had children and MS.
The finding of an inverse association between sun exposure during childhood and early
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CGRP calcitonin gene related peptide
CI confidence interval
CMV cytomegalovirus
CNS central nervous system
CSF cerebrospinal fluid
DSS Disability Status Scale
EAE experimental allergic encephalomyelitis
EA-R early antigen complex (restricted), viral protein of Epstein-Barr virus
EA-D early antigen complex (diffuse), viral protein of Epstein-Barr virus
EBNA Epstein-Barr nuclear antigen, viral protein of Epstein-Barr virus
EBV Epstein-Barr virus
EDSS Expanded Disability Status Scale
HHV human herpes virus
HLA human leukocyte antigen
HSV herpes simplex virus
ICC intraclass correlation coefficient






MBP myelin basic protein
MED mean erythemal dose
MHC major histocompatibility complex
MOG myelin oligodendrocyte glycoprotein









TNF tumour necrosis factor
TGF transforming growth factor
UVR ultraviolet radiation
VCA viral capsid antigen, viral protein of Epstein-Barr virus
VZV varicella zoster virus

